IL33 and Alzheimer disease: Serum IL-33 level was significantly higher in the AD mice than in the control mice (P ≤ 0.0001); meanwhile, AS1517499 administration markedly ameliorated this increase caused by DNCB (P ≤ 0.0001, Fig. 6B).